Summary tables comparing neoplastic disorders: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
Line 43: | Line 43: | ||
|colspan="1" style = "background:#00b8e6;color:black; font-size:80%"|20:40 '''wk''' | |colspan="1" style = "background:#00b8e6;color:black; font-size:80%"|20:40 '''wk''' | ||
|colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"|<5% | |colspan="1" style = "background:#E6FAFF;color:black; font-size:80%"|<5% | ||
|colspan="1" style = "background:#00b8e6;color:black; font-size:80%"|40:80 | |||
|colspan="1" style = "width: 8%; background:#004466;color:white;font-size:80%"|>80 '''Stg''' | |||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:navy;" |'''CD19''' | |colspan="1" style = "font-size:90%; color:navy;" |'''CD19''' |
Revision as of 10:57, 22 June 2023
Immunophenotype LPD | |||||
---|---|---|---|---|---|
Marker | CLL | MCL | FL | MZL | HCL |
κ/λ | 40:80 wk | >80 | 40:80 var | >80 | >80 stg |
FMC7 | 20:40 wk | 40:80 | 20:40 wk | 40:80 | >80 Stg |
CD5 | >80 | >80 longer | <5% | 5-20 | 5-20 |
CD10 | 5-20 | 5-20 | >80 Stg | 5-20 | 5-20 |
CD11C | 20:40 wk | 20:40 wk | <5% | 40:80 | >80 Stg |
CD19 | >80 | >80 | 40:80 | ||
CD20 | >80 | >80 | >80 | ||
CD23 | >80 | 5-20 | 40:80 | ||
CD25 | 20:40 wk | 20:40 wk | 5-20 wk | ||
CD38 | 20:40 | >80 | >80 | ||
CD43 | >80 | 40:80 | <5% | ||
CD79b | >80 wk | >80 | >80 | ||
CD103 | <5% | <5% | <5% | ||
CD138 | <5% | <5% | <5% | ||
CD200 | >80 | <5% | <5% |
Key to table:
Key to colour code Click for link
Key to expression code Click for link